Worth looking at again: Addressing Myths and Misinformation on COVID-19 and Other infectious Disease Matters

1) Myth: The needles used in vaccination are extraordinarily large:

Answer: no they are 22-25 gauge; standard; sizes used to vaccinate dogs, cats and people; the 25 ga size used to collect small amounts of blood from babies and dogs and cats. See https://www.cdc.gov/vaccines/covid-19/downloads/covid19-vaccine-quick-reference-guide-2pages.pdf?ACSTrackingID=USCDC_2120-DM53231&ACSTrackingLabel=New%20Reference%20Tools%20Are%20Available%21&deliveryName=USCDC_2120-DM53231. Note: microchip delivery needles are much larger at twelve gauge.

2) Myth: The vaccines cause COVID.

Answer: no vaccine used in the US is a complete modified live SARS-CoV-2 virus; they are either mRNA vaccines that produce only the non-infectious spike protein of the virus or adenovirus carrier viruses producing the same spike protein; these adenovirus strains do not cause disease in humans. Other adenoviruses do.

3) Myth: The vaccines cause sterility.

Answer: I have addressed this before in an earlier post on Syncytin 1 (Why a Viral Protein is Critical to Human Fetal Development: Syncytin I is Not a Cause of Concern for Autoimmunity or Sterility from a SARS-CoV-2 Vaccine: Twisting the Truth). This is an ancient viral protein essential to placenta formation in humans which they are completely tolerant to. If SARS-CoV-2 caused autoimmunity to this protein, we would have seen it in those naturally infected (no reports of this) before we would have seen it in those vaccinated.

4) Myth: Anaphylactic severe reactions to the vaccine are worse for COVID vaccines than other vaccines,

Answer: the rare reports of severe reactions to the vaccines are no more than to any other vaccines. In light of J&J and AstraZeneca vaccines problems, a further explanation is needed. The reactions, although one in a million, have included one death and a critical illness. CDC and the U.S. Food and Drug Administration (FDA) are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the J&J COVID-19 vaccine that were reported to the Vaccine Adverse Events Reporting System (VAERS). In spite of attributing these reactions to the adenovirus vectors, the combination ok of viral vector with coronavirus antigens may be the complex culprit. Interesting that Ebola adenovirus based vaccine has not led to reported rare coagulopathies associated with autoimmunity like COVID adenovirus vaccines. The same Adenovirus 26 vector used for Johnson&Johnson COVID vaccine was used for Ebola vaccine without the same rare coagulopathy. SARS-CoV-2 triggers complement formation and activation in the lungs (and other tissues) which activates the Th17 pathway linked to autoimmunity (like auto-antibodies to platelet factor 4 associated with bound heparin seen in these rare reactions to vaccines) leading to thrombocytopenia and thrombosis. SARS-CoV.2 itself, not just adenovirus, profoundly affects clotting (95 times more likely with SARS-CoV-2 infection than general population and 10 times more likely from infection than vaccination). Also complement activation triggers blood clotting. These responses are also triggered by other infectious agents like hepatitis C virus (most common) and the ulcer causing bacteria Helicobacter pylori and other infectious exposure: mumps-measles-rubella (MMR) vaccine (1 in 40,000 administrations), and cytomegalovirus or Varicella-Zoster virus (cause of chicken pox and shingles). https://theconversation.com/johnson-and-johnson-vaccine-suspension-what-this-means-for-you-158923; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713875/pdf/nihms-123860.pdf; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882841/pdf/JEM_20092301.pdf; https://immunology.sciencemag.org/content/immunology/6/58/eabg0833.full.pdf; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672858/pdf/nihms472010.pdf; https://www.nejm.org/doi/pdf/10.1056/NEJMoa2104840?articleTools=true,